[1] TANG LL, CHEN WQ, XUE WQ, et al.Global trends in incidence and mortality of nasopharyngeal carcinoma[J].Cancer Letters, 2016, 374(1):22. doi: 10.1016/j.canlet.2016.01.040
[2] CHEN YP, CHAN ATC, LE QT, et al.Nasopharyngeal carcinoma[J].Lancet, 2019, 394(10192):64. doi: 10.1016/S0140-6736(19)30956-0
[3] LEE AW, MA BB, WT NG, et al.Management of nasopharyngeal carcinoma:current practice and future perspective[J].J Clin Oncol, 2015, 33(29):56.
[4] LEEAW, TUNG SY, DT CHUA, et al.Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma[J].J Natl Cancer Inst, 2010, 102(15):88.
[5] 梁雷锋, 林展.复发鼻咽癌治疗的新进展[J].中国临床新医学, 2019, 12(3):342.
[6] NG WT, TUNG SY, LEE V, et al.Concurrent-adjuvant chemoradiation therapy for stage Ⅲ-IVB nasopharyngeal carcinoma-exploration for achieving optimal 10-year therapeutic ratio[J].Int J Radiat Oncol Biol Phys, 2018, 101(5):78.
[7] 郭兴裕.糖酵解抑制剂对胃癌细胞MGC-803的影响及其机制研究[D].桂林: 广西医科大学, 2017.
[8] 张海丽, 曾常茜, 郑学仿.3-溴丙酮酸对人肝癌HepG-2细胞增殖和凋亡的影响[J].广西医科大学学报, 2010, 27(2):183.
[9] YANG Y, ZHU G, DONG B, et al.The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming[J].Cancer Letters, 2019, 453:170. doi: 10.1016/j.canlet.2019.03.054
[10] 邹雪.3-溴丙酮酸诱导鼻咽癌细胞死亡的作用及其机制[D].蚌埠: 蚌埠医学院, 2016.
[11] 赵素容, 张媛媛, 吴成柱, 等.3-溴丙酮酸增强肝癌细胞对顺铂敏感性的作用[J].南方医科大学学报, 2014, 34(1):25.
[12] 李其响.3-溴丙酮酸对乳腺癌细胞的细胞毒性依赖于MCT1表达[D].蚌埠: 蚌埠医学院, 2018.
[13] SZCZUKA I, GAMIAN A, TERLECKI G.3-Bromopyruvate as a potential pharmaceutical in the light of experimental data[J].Postepy Hig Med Dosw, 2017, 71:88.
[14] IHRLUND LS, HERNLUND E, KHAN O, et al.3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs[J].Mol Oncol, 2008, 2(1):94.
[15] DEVORKIN L, PAVEY N, CARLETON G, et al.Autophagy regulation of metabolism is required for CD8(+) T cell anti-tumor immunity[J].Cell Rep, 2019, 27(2):502.
[16] JAGUST P, LUXAN-DELGADO B DE, PAREJO-ALONSO B, et al.Metabolism-based therapeutic strategies targeting cancer stem cells[J].Front Pharmacol, 2019, 10:203. doi: 10.3389/fphar.2019.00203
[17] MARTINEZ-OUTSCHOOM UE, PESTELL RG, HOWELL A, et al.Energy transfer in "parasitic" cancer metabolism[J].Cell Cycle, 2011, 10(24):4208. doi: 10.4161/cc.10.24.18487
[18] WARD PS, THOMPSON CB.Metabolic reprogramming:acancer hallmark even warburg did not anticipate[J].Cancer Cell, 2012, 21(3):297. doi: 10.1016/j.ccr.2012.02.014
[19] LIU Y, FANG S, SUN Q, et al.Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress[J].Biochem Biophys Res Commun, 2016, 480(3):415.
[20] ISHIGURO Y, KOBAYASHI M, IDENO M, et al.Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity[J].Int J Pharm, 2018, 551(1-2):97. doi: 10.1016/j.ijpharm.2018.08.039
[21] CHEN Y, WEI L, ZHANG X, et al.3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5[J].Oncol Rep, 2018, 40(5):2435.
[22] ZOU X, ZHANG M, SUN Y, et al.Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells[J].Oncol Rep, 2015, 34(4):1895.
[23] PULASKI L, JATCZAK-PAWLIK I, SOBALSKA-KWAPIS M, et al.3-Bromopyruvate induces expression of antioxidant genes[J].Free Radic Res, 2019, 53(2):170. doi: 10.1080/10715762.2018.1541176
[24] LIS P, DYLAG M, NIEDZWIECKA K, et al.The HK2 dependent "warburg effect" and mitochondrial oxidative phosphorylation in cancer:targets for effective therapy with 3-bromopyruvate[J].Molecules, 2016, 21(12):1730. doi: 10.3390/molecules21121730
[25] TRAN Q, LEE H, PARK J, et al.Targeting cancer metabolism-revisiting the warburg effects[J].Toxicol Res, 2016, 32(3):177. doi: 10.5487/TR.2016.32.3.177
[26] YADAV S, PANDEY SK, KUMAR A, et al.Antitumor and chemosensitizing action of 3-bromopyruvate:implication of deregulated metabolism[J].Chem Biol Interact, 2017, 270:73. doi: 10.1016/j.cbi.2017.04.015
[27] LEBELO MT, JOUBERT AM, VISAGIE MH.Warburg effect and its role in tumourigenesis[J].Arch Pharm Res, 2019, 42(10):833. doi: 10.1007/s12272-019-01185-2
[28] FAN T, SUN G, SUN X, et al.Tumor energy metabolism and potential of 3-bromopyruvate as an inhibitor of aerobic glycolysis:implications in tumor treatment[J].Cancers (Basel), 2019, 11(3):317. doi: 10.3390/cancers11030317
[29] STAGG J, SMYTH MJ.Extracellular adenosine triphosphate and adenosine in cancer[J].Oncogene, 2010, 29(39):5346. doi: 10.1038/onc.2010.292
[30] SCHENK RL, STRASSER A, DEWSON G.BCL-2:long and winding path from discovery to therapeutic target[J].Biochem Biophys Res Commun, 2017, 482(3):459.
[31] WENG JR, BAI LY, CHIU SJ, et al.Divaricoside exerts antitumor effects, in part, by modulating Mcl-1 in human oral squamous cell carcinoma cells[J].Comput Struct Biotechnol J, 2019, 17:151. doi: 10.1016/j.csbj.2019.01.004
[32] PENA-BLANCO A, GARCIA-SAEZ AJ.Bax, Bak and beyond-mitochondrial performance in apoptosis[J].The FEBS Journal, 2018, 285(3):416. doi: 10.1111/febs.14186